A Biotech company solely focused on brain disorders, pioneering a unique platform to develop a new class of therapies for Autism, Alzheimer's, and Glioblastoma.neuro-nos.com Boston, MAJoined October 2024
Glioblastoma (GBM) is the most aggressive brain cancer, with survival often measured in months despite current treatments.
At NeuroNOS, we’re developing a novel nNOS inhibitor to rebalance nitric oxide signaling that fuels tumor growth.
#NeuroNOS#Glioblastoma#braincancercure
In a landmark Redox Biology review, our CSO Prof. @haitham_amal (@neuronos) with Tripathi & Kartawy highlighted how NO dysregulation drives brain disorders.
We’re building on these insights with a selective nNOS inhibitor for ASD. @Elsevier#NeuroNOS#AutismResearch#NitricOxide
#ThrowbackThursday: Prof. @haitham_amal’s lab (our CSO) found disrupted autophagy proteins in two ASD models, driven by NO imbalance. Blocking nNOS restored normal function—reinforcing NeuroNOS’s approach to rebalance NO & tackle core ASD biology. #AutismResearch#NeuroNOS
Nitric oxide (NO) is vital in balance, too much from nNOS fuels nitrosative stress, disrupting synapses. Research by our CSO, Prof. @haitham_amal, links this to ASD. At NeuroNOS, we’re developing a selective nNOS inhibitor to restore brain balance.
#ASD#BrainHealth#NitricOxide
#ThrowbackThursday: A 2022 Free Radical Biology & Medicine paper by @haitham_amal revealed how nitric oxide disrupts NMDA receptor signaling in ASD models.
At NeuroNOS, we’re targeting that biology with our selective nNOS inhibitor.
#ASD#NitricOxide#TBT@ElsevierConnect
Lifetime autism care may exceed $4M per person (Zhao et al., 2024). Most treatments manage symptoms, few target root biology.
At NeuroNOS, we’re developing a first-in-class drug to rebalance NO signaling in ASD.
#NeuroNOS#Autism#ASD#NitricOxide#HealthEconomics
📽️Sneak peak: We spoke with three world-class scientists, joined by our two extraordinary Nobel Laureates who serve on our Scientific Advisory Board (SAB), as well as our CSO, to discuss our novel small-molecule nitric oxide inhibition platform for autism.
#NobelPrize#Autism
Proud to share that our CSO, Prof. @haitham_amal Amal, joins the #Synchrony2025 Roundtable on neuroenergetics in autism.
Excess NO → oxidative stress → mitochondrial strain. Our nNOS-targeted small molecule aims to restore balance. #NO#Autismlinkedin.com/posts/the-brai…
Big news from @Neuro_NOS@NobelPrize Dan Shechtman joined our Scientific Advisory Board, becoming the second Nobel Prize winner on the team alongside Prof. Roger Kornberg.
His groundbreaking insights will help advance our therapy development for #autism and #Alzheimer…
147 Followers 581 FollowingGenomic Press is a world-class neuroscience publishing platform, providing the most exciting emerging science unparalleled visibility. Julio Licinio, Publisher.
74 Followers 499 FollowingRan Kime, a recluse, writer, poet, musician, and an unwilling sparring partner of the imposter syndrome. Channeling #HankChinaski as a spirit animal.
2K Followers 2K FollowingNuestra misión es mejorar la calidad de vida de las personas afectadas por el síndrome de Phelan-McDermid.
📲 Dona por Bizum: 02019
497 Followers 1K FollowingThe wrath of God is being revealed from heaven against all godlessness of people, who suppress the truth in wickedness.
#Bitcoin
1K Followers 0 FollowingWatch for copy cats. We do not ever ask to invest your money. We post simple analytics within smaller cap bio/pharma for entertainment purposes only.
4K Followers 80 FollowingExperienced independent investor group, since late 1990, focused on public biotech companies in Nordic markets. We let our performance speak for itself.
224K Followers 4K FollowingThe U.S. government’s agency for cancer research. Part of @NIH. Engagement ≠ endorsement. Questions about cancer? Reach us here: https://t.co/yQAi9x4Obg
50K Followers 532 FollowingMedical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.
484 Followers 309 FollowingTo understand how the brain works, the brain must be working. We study active touch in a naive yet earnest struggle to solve the brain.
154 Followers 117 FollowingI am an assistant professor at Oberlin College interested in dopamine, decision making, and reinforcement. Father of 2, avid musician, and amateur gardener.
1K Followers 209 FollowingNeuroscience Chair & Director of Drug Discovery Institute @IcahnMountSinai. Researching the molecular neurobiology of addiction, obesity & schizophrenia.
12 Followers 159 FollowingCEO of NeuroNOS, developing breakthrough treatments for autism and Alzheimer’s. Passionate about science, innovation, and the future.
28K Followers 577 FollowingOfficial X account of NIH's National Institute on Aging. Dedicated to improving the health of older adults through research. Privacy: https://t.co/6XA3jNUXwc
48K Followers 2K FollowingHealthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
16K Followers 7K FollowingClinical Oncologist from Texas🇺🇸Director of @OncoAlert 🚨 Proudly NIH, NCI & MDA trained. An ounce of prevention equals a pound of cure. Views are own🌏
8K Followers 1K FollowingUpdates on events, activities, and opportunities held by the European School of Oncology, e-learning activities, and news from the ESO College!
17K Followers 209 FollowingSVP Oncology Global Development @Amgen, Physician-Scientist, Medical Oncologist, immune and molecular target-believer, Tweets my own
14K Followers 1K FollowingSWOG Cancer Research Network runs publicly funded clinical trials that have saved 3 million+ years of life. Founded by the National Cancer Institute in 1956.
8K Followers 1K FollowingGiuseppe Curigliano, MD, PhD, Professor at University of Milan and Head of Phase I Division at IEO, ESMO Open EiC, Tweets are my own
3K Followers 833 FollowingThe Breast International Group is the largest global network of academic research groups dedicated to curing breast cancer. 🌎
4K Followers 2K FollowingMD, Medical Oncologist🇮🇹•Research Physician at @JulesBordet Institute in Brussels🇧🇪 Great interest in #BreastCancer and #ImmunoOncology
5K Followers 312 FollowingProfessor Medical Oncologist at Hospital University of Valencia Scientific director @Incliva_iis Editor @ESMO_OPEN @Annals_Oncology Past President @myESMO
18K Followers 460 FollowingAssociate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Chair of @myESMO YOC. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.
10K Followers 449 Following@ASCO President. Representing more than 50K oncology professionals making a difference in cancer care. Opinions my own. Interviews: [email protected]
3K Followers 132 FollowingMedical Oncologist, UCLA. Passionate about accelerating innovative research and fostering academic mentorship to improve patient outcomes.
14K Followers 556 FollowingBreast cancer specialist and professor @DanaFarber Cancer Institute and @HarvardMed. Tweets are my own and not medical advice. COI disclosure: no COI.